South Rampart Pharma, Inc.
PrivateLast Round
Series A
Apr 10, 2025
Total Funding Raised
$2.3M
Company Overview
South Rampart Pharma, Inc. operates in Healthcare & Life Sciences and is based in New Orleans, Louisiana. Its latest recorded funding round was a Grant round in September 2023.
South Rampart Pharma, Inc. is a clinical-stage biopharmaceutical company that develops novel, non-opioid small molecule therapeutics designed to treat pain while avoiding the organ toxicity and addiction risks associated with current analgesics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
South Rampart Pharma, Inc. Comparables
Compare South Rampart Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latigo Biotherapeutics | 87% | |
| Akelos Inc. | 84% | |
| Eli Lilly and Company | 81% |
For institutional investors. Book with your work email.
South Rampart Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 10, 2025 | ||||
| Grant | Sep 21, 2023 | ||||
| Grant | Sep 29, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
South Rampart Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gulf South Angels | Series A |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 232% MoM, reaching 1.4K.
- Jun 20, 2026
Monthly visitors grew 147% MoM.
For institutional investors. Book with your work email.
South Rampart Pharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about South Rampart Pharma, Inc.'s valuation, stock price, and market status.
Is South Rampart Pharma, Inc. a public or private company?
South Rampart Pharma, Inc. is a private company.
What is the current stock price of South Rampart Pharma, Inc.?
South Rampart Pharma, Inc. is a private company, so its shares have no public market price. Caplight tracks South Rampart Pharma, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is South Rampart Pharma, Inc. worth (valuation)?
Valuation information for South Rampart Pharma, Inc. is not publicly available.
Can I buy South Rampart Pharma, Inc. stock?
South Rampart Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was South Rampart Pharma, Inc.'s last funding round?
South Rampart Pharma, Inc.'s most recent funding round was Series A on April 10, 2025.
Who are the main investors in South Rampart Pharma, Inc.?
Key investors in South Rampart Pharma, Inc. include Gulf South Angels, NIH RADx.
Will South Rampart Pharma, Inc. IPO soon?
No public IPO plans have been announced for South Rampart Pharma, Inc..
How can I track South Rampart Pharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in South Rampart Pharma, Inc.'s shares on secondary markets.